Fundraising advisory for medtech startups

Medtech founders change how healthcare works, but scaling innovation in a regulated market requires more than great technology

It requires capital discipline, regulatory alignment, and investor trust.

At dups, we help medtech startups and scale-ups secure and structure the capital they need to grow. Our integrated legal and financial team supports you from investment readiness to closing, ensuring your funding strategy reflects your stage, risk profile, and regulatory pathway. Because in healthcare, clarity builds confidence, and confidence drives capital.

Why medtech fundraising is different

Medtech funding sits at the intersection of innovation, regulation, and evidence. Investors look for proof, not promises. That means you need a structure that communicates readiness and mitigates risk.

Key challenges include regulatory milestones (CE, FDA, MDR compliance) that impact valuation, capital intensity (especially in hardware or clinical validation), long sales cycles and payer complexity, and a hybrid investor landscape, mixing VCs, corporates, and public funds. We help you navigate these dynamics with clear models, solid documentation, and a coherent capital strategy.

Our medtech funding approach

1. Capital strategy design

We start by aligning your business roadmap with your regulatory and clinical milestones. Then we design a capital structure that supports both, balancing equity, convertible, and non-dilutive funding.

Depending on your stage, that may include early equity (angels, seed, medtech VCs), grant and innovation funding (EIC, Innoviris, Bpifrance, EU programs), convertible or milestone-based instruments, and strategic or corporate investors. Our goal: ensure every round builds optionality, not complexity.

2. Financial modeling and investor materials

We prepare your financial story to stand up to investor scrutiny. Our models integrate development and regulatory timelines, clinical trial and certification costs, commercialization scenarios and revenue logic, valuation and dilution modeling, and sensitivity and runway analysis.

We also craft pitch decks, investment memos, and data rooms that align your science, market, and numbers into a single, credible story.

3. Legal structuring and negotiation

Medtech fundraising involves unique legal complexities: IP protection, regulatory compliance, and milestone-linked funding. Our legal and financial experts work together to ensure total consistency between your financial logic and your deal terms.

We manage term sheet design and negotiation, convertible or milestone-based instruments (SAFE, notes, tranches), shareholder and governance setup, IP and clinical data ownership, and closing coordination and regulatory documentation alignment. We turn regulatory complexity into structured clarity, so your investors stay confident, not cautious.

4. Scaling and growth capital

Once your medtech product reaches market entry or traction, we help you prepare for growth-stage capital: Series B+ expansion rounds, venture debt or hybrid financing, corporate or strategic partnerships, and pre-M&A or pre-exit preparation.

We ensure every new deal builds on a clean legal and financial base with no structural friction and no value leakage.

What makes dups different

At dups, we combine dealmaking expertise with deep understanding of regulated innovation. We know what healthcare investors expect, how corporates negotiate, and where founders lose leverage.

Our integrated team bridges law and finance, so your valuation model, term sheet, and governance all tell the same story. We work fast, think strategically, and focus on one outcome: getting your deal closed on the right terms.

Deliverables you can expect

We deliver a complete medtech funding advisory package, including:

• Capital structure and funding roadmap
• Financial model and regulatory milestone mapping
• Pitch deck and investor memo preparation
• Legal structuring and negotiation support
• Convertible or milestone-based deal design
• Closing coordination and compliance review
• Integration of grants and hybrid funding sources

Each deliverable is designed to be credible, aligned, and investor-ready.